Kunming Biomed International (KBI)

  • Booth: 946

KBI: A CRO company specialized on NHP pharmacology services

Kunming Biomed International (KBI), located in southwest China, is a science-based CRO providing preclinical services specialized in non-human primates. The core competency of KBI is to provide NHP disease models to test drug candidates and medical devices for their pharmacological effects and biocompatible repairs. KBI also conducts adjacency studies in PK/PD, in vitro pharmacology, histology/pathology, and preliminary toxicology. KBI has already achieved AAALAC accreditation

Send Email

Type your information and click "Send Email" to send an email to this exhibitor. To return to the previous screen without saving, click "Reset".